These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 1725157)
1. Centrally coinjected galanin and a 5-HT1A agonist act synergistically to produce vasodepressor responses in the rat. Hedlund PB; Aguirre JA; Narvaez JA; Fuxe K Eur J Pharmacol; 1991 Oct; 204(1):87-95. PubMed ID: 1725157 [TBL] [Abstract][Full Text] [Related]
2. Activation of 5-hydroxytryptamine1A receptors increases the affinity of galanin receptors in di- and telencephalic areas of the rat. Hedlund P; von Euler G; Fuxe K Brain Res; 1991 Sep; 560(1-2):251-9. PubMed ID: 1836971 [TBL] [Abstract][Full Text] [Related]
4. Effects of galanin on 8-OH-DPAT induced decrease in body temperature and brain 5-hydroxytryptamine metabolism in the mouse. Patel S; Hutson PH Eur J Pharmacol; 1996 Dec; 317(2-3):197-204. PubMed ID: 8997601 [TBL] [Abstract][Full Text] [Related]
5. Galanin-(1-15), but not galanin-(1-29), modulates 5-HT1A receptors in the dorsal hippocampus of the rat brain: possible existence of galanin receptor subtypes. Hedlund PB; Finnman UB; Yanaihara N; Fuxe K Brain Res; 1994 Jan; 634(1):163-7. PubMed ID: 7512426 [TBL] [Abstract][Full Text] [Related]
6. Hypotensive effects of 5-HT1A receptor activation: ventral medullary sites and mechanisms of action in the rat. Helke CJ; McDonald CH; Phillips ET J Auton Nerv Syst; 1993 Feb; 42(2):177-88. PubMed ID: 8450176 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. Fozard JR; Mir AK; Middlemiss DN J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400 [TBL] [Abstract][Full Text] [Related]
8. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat. Gradin K; Pettersson A; Hedner T; Persson B J Neural Transm; 1985; 62(3-4):305-19. PubMed ID: 3161997 [TBL] [Abstract][Full Text] [Related]
9. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor. Tricklebank MD; Neill J; Kidd EJ; Fozard JR Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat. Dreteler GH; Wouters W; Saxena PR Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096 [TBL] [Abstract][Full Text] [Related]
11. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. Millan MJ; Bervoets K; Colpaert FC J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033 [TBL] [Abstract][Full Text] [Related]
12. Intraventricular galanin modulates a 5-HT1A receptor-mediated behavioural response in the rat. Misane I; Razani H; Wang FH; Jansson A; Fuxe K; Ogren SO Eur J Neurosci; 1998 Apr; 10(4):1230-40. PubMed ID: 9749777 [TBL] [Abstract][Full Text] [Related]
13. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors. Clarke RW; Ogilvie J; Houghton AK Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958 [TBL] [Abstract][Full Text] [Related]
14. Central nervous actions of serotonin and a serotonin1A receptor agonist: cardiovascular excitation at low doses. Dedeoğlu A; Fisher LA J Pharmacol Exp Ther; 1991 Apr; 257(1):425-32. PubMed ID: 1826928 [TBL] [Abstract][Full Text] [Related]
15. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat. Deckert V; Chaouloff F; Richer C; Elghozi JL Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665 [TBL] [Abstract][Full Text] [Related]
16. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats. Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310 [TBL] [Abstract][Full Text] [Related]
17. Characterization of galanin and 5-HT1A receptor coupling to adenylyl cyclase in discrete regions of the rat brain. Billecocq A; Hedlund PB; Bolaños-Jiménez F; Fillion G Eur J Pharmacol; 1994 Oct; 269(2):209-17. PubMed ID: 7531647 [TBL] [Abstract][Full Text] [Related]
18. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin. Marsden CA; Martin KF Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656 [TBL] [Abstract][Full Text] [Related]
19. Comparison between the cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) and clonidine in the conscious sino-aortic denervated rat. Petty MA; Kintz J; Di Francesco GF; Fozard JR J Auton Pharmacol; 1988 Dec; 8(4):267-76. PubMed ID: 2855330 [TBL] [Abstract][Full Text] [Related]
20. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine. Blier P; Serrano A; Scatton B Synapse; 1990; 5(2):120-33. PubMed ID: 2137943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]